Condition

Cardiovascular Insufficiency

ClinicalTrials.gov condition label

Clinical trials2

Recruiting1

Common interventions6

Lead sponsors shown2

Clinical trials

2 shown

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine CareNCT03882580 · 2019-03-01

RECRUITING

Validation of a Walk-Time Limit Test (WTLT) Derived from the 6-Minute Walk Test (6-MWT) in Patients with Chronic Cardiovascular or Respiratory DiseasesNCT04086953 · 2020-02-20

TERMINATED

Common interventions

6-minute walk testDIAGNOSTIC_TEST1Anti-Cancer AgentsDRUG1Endurance shuttle walk testDIAGNOSTIC_TEST1Incremental shuttle walk testDIAGNOSTIC_TEST1Respiratory Functional AssessmentDIAGNOSTIC_TEST1Walk-Time Limit TesDIAGNOSTIC_TEST1

Leading sponsors

Groupe Hospitalier Pitie-Salpetriere1University Hospital, Brest1

Trial status mix

RECRUITING1

TERMINATED1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.